Vanilloid (capsaicin) receptors in health and disease

American Journal of Clinical Pathology

Volumn 118, Issue 1, 2002, Pages 110-121

  Szallasi, Arpad ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anandamide; Capsaicin; Resiniferatoxin; Vanilloid receptor VR1

Indexed keywords

ANANDAMIDE; CAPSAICIN; RESINIFERATOXIN; VANILLOID RECEPTOR;

CLINICAL TRIAL; DESENSITIZATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TOLERABILITY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MOLECULAR BIOLOGY; NEUROPATHY; PRIORITY JOURNAL; PRURITUS; RECEPTOR DOWN REGULATION; REVIEW; SENSORY NERVE CELL;

ANIMALS; ARACHIDONIC ACIDS; CAPSAICIN; DISEASE; DITERPENES; DRUG THERAPY; HEALTH; HUMANS; NEURONS; PATHOLOGY; POLYUNSATURATED ALKAMIDES; RECEPTORS, DRUG;

EID: 0036303675     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7AYY-VVH1-GQT5-J4R2     Document Type: Review

References (98)

1. Capsaicin type pungent agents producing pyrexia
2. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
3. Physiological gustatory sweating in warm climate
4. The neuropharmacology of capsaicin: A review of some recent observations
5. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes
6. Vanilloid (capsaicin) receptors and mechanisms
7. The capsaicin receptor: A heat-activated ion channel in the pain pathway
8. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
9. Sense and specificity: A molecular identity for nociceptors
10. Capsaicin receptor in the pain pathway
11. Chilies: From antiquity to urology
12. Intravesical neuromodulatory drugs: Capsaicin and resiniferatoxin to treat the overactive bladder
13. Vanilloid receptor ligands: Hopes and realities for the future
14. Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties
15. From worm to man: Three subfamilies of TRP channels
16. OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans
17. The cloned capsaicin receptor integrates multiple pain-producing stimuli
18. Acid potentiation of the capsaicin receptor determined by a key extracellular site
19. Ruthenium red as a capsaicin antagonist
20. The activation mechanism of rat vanilloid receptor 1 by capsaicin involves the pore domain and differs from the activation by either acid or heat
21. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel
22. Functional analysis of capsaicin receptor (vanilloid receptor subtype 1) multimerization and agonist responsiveness using a dominant negative mutation
23. Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia
24. 2+ dependence in rat trigeminal ganglion cells
25. Analysis of the native quaternary structure of vanilloid receptor 1
26. The genomic organization of the gene encoding the vanilloid receptor: Evidence for multiple splice variants
27. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1
28. The genomic region encompassing the nephropathic cystinosis gene (CTNS): Complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion
29. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
30. Transient expression of vanilloid receptor subtype 1 in rat cardiomyocytes during development
31. A capsaicin receptor homologue with a high threshold for noxious heat
32. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I
33. Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2
34. Molecular cloning of an N-terminal splice variant of the capsaicin receptor: Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes
35. Cloning of a stretch-inhibitable nonselective cation channel
36. The stretch-inactivated channel, a vanilloid receptor variant, is expressed in small-diameter sensory neurons in the rat
37. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor
38. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity
39. Significant linkage between bipolar affective disorder and chromosome 12q24
40. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption
41. 2+ channel
42. A unified nomenclature for the superfamily of TRP cation channels
43. Actions of capsaicin on sensory receptors
44. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
45. New perspectives on enigmatic vanilloid receptors
46. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat
47. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells
48. Immunoreactivity of VR1 on epidermal keratinocyte of human skin
49. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor
50. Quantification of cutaneous sensory nerves and their substance P content in psoriasis
51. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris
52. Sensory neurons in the intestine
53. Capsaicin-sensitive afferents and their role in gastroprotection: Update
54. Helicobacter pylori: Novel therapies
55. Phosphoinositide 3-kinases in the gut: A link between inflammation and cancer?
56. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone
57. Chili pepper consumption and gastric cancer in Mexico: A case control study
58. 3 purinoceptor, and IB4 binding sites
59. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder
60. 3-deficient mice
61. Cutaneous lesions in capsaicin-treated rats: Atrophic role for capsaicin-sensitive afferents?
62. Resiniferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret
63. Distribution and characterization of vanilloid receptors in the rat stomach
64. Characterization of functional vanilloid receptors expressed by mast cells
65. Identification of functional vanilloid receptors in human bladder urothelial cells using a nitric oxide microsensor technique and reverse transcriptase polymerase chain reaction
66. Intracellular ATP increases capsaicin-activated channel activity by interacting with nucleotide-binding domains
67. A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application
68. Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules)
69. Protons: Small stimulants of capsaicin-sensitive sensory nerves
70. Potential of calcitonin-gene related peptide in coronary cardiac disease
71. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances
72. Induction of vanilloid receptor channel activity by protein kinase C
73. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
74. Are endocannabinoids endogenous ligands for the VR1 capsaicin receptor?
75. Anandamide: Some like it hot
76. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (VR1)
77. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
78. Propofol activates vanilloid receptor channels expressed in human embryonic kidney 293 cells
79. Vanilloid receptor-1 is essential for inflammatory hyperalgesia
80. Treatment of intractable pain with topical large-dose capsaicin: Preliminary report
81. Perspectives of capsaicin-type agents in pain therapy and research
82. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs: A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders
83. Intravesical capsaicin and resiniferatoxin therapy: Spicing up the ways to treat the overactive bladder
84. Intravesical capsaicin therapy: A review
85. Intravesical neuromodulatory drugs: Capsaicin and resiniferatoxin to treat the overactive bladder
86. Vanilloids and the overactive bladder
87. Intravesical treatment of overactive bladder
88. Suppression of bladder hyperreflexia by intravesical resiniferatoxin
89. Urodynamic effects of intravesical resiniferatoxin in humans: Preliminary results in stable and unstable detrusor
90. Intravesical resiniferatoxin (RTX) treatment of detrusor hyperreflexia: Results of a randomized, double-blind, placebo-controlled, multicenter trial
91. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: Correlation with sensory function
92. Ultrastructural changes in the composition of lamina propria nerves following intravesical capsaicin therapy
93. Treating the human bladder with capsaicin: Is it safe?
94. Vanilloid receptor 1 immunoreactivity in inflamed human bowel
95. 3) receptors in Hirschsprung's intestine
96. Failure of capsaicin-containing red pepper sauce suspension to induce esophageal motility response in patients with Barrett's esophagus
97. Adverse consequences of capsaicin exposure in health care workers
98. Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum, and pepper spray products